Evidence map›Paper›PMID 24692660›Full record

ArticleNucleic acids research2014

AMPK regulates histone H2B O-GlcNAcylation.

Qiuran Xu, Caihong Yang, Yu Du, Yali Chen, Hailong Liu, Min Deng, Haoxing Zhang, Lei Zhang, Tongzheng Liu, Qingguang Liu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Epigenetic alterations in Myeloid Malignancies.Advances in experimental medicine and biology · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2023
    Article
  19. The role of O-GlcNAcylation in development.Development (Cambridge, England) · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Qiuran XuDepartment of Hepatobiliary Surgery, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
Caihong YangDepartment of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Yu DuDepartment of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Yali ChenState Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Hailong LiuState Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Min DengDivision of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
Haoxing ZhangState Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
Lei ZhangDivision of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
Tongzheng LiuDivision of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
Qingguang LiuDepartment of Hepatobiliary Surgery, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
Liewei WangMolecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA peihuadong@126.com.
Zhenkun LouDivision of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA peihuadong@126.com.
Huadong PeiState Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China peihuadong@126.com.
Beijing Proteome Research Center · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNMayo Clinic · USMayo Clinic in Florida · USHuazhong University of Science and Technology · CNMayo Clinic in Arizona · USTongji Hospital · CN

Funding

Targeted MV-CEA as a Potent Antitumor Agent against GBMP50CA108961 · NCI · MAYO CLINIC ROCHESTER · PI O'NEILL, BRIAN PATRICK · 2004 to 2015
$22.5M
Ubiquitination and the DNA Damage Response PathwayR01CA130996 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2008 to 2018
$3.3M
Regultion of p53 DeubiquitinationR01CA148940 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2011 to 2015
$1.6M
Regulation of SirT1 by Deleted in Breast Cancer 1 (DBC1)R01CA129344 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2009 to 2013
$1.5M
NCI NIH HHS P50 CA108961NCI NIH HHS R01 CA129344NCI NIH HHS R01 CA130996NCI NIH HHS R01 CA148940
6 · The paper itself

Abstract

Histone H2B O-GlcNAcylation is an important post-translational modification of chromatin during gene transcription. However, how this epigenetic modification is regulated remains unclear. Here we found that the energy-sensing adenosine-monophosphate-activated protein kinase (AMPK) could suppress histone H2B O-GlcNAcylation. AMPK directly phosphorylates O-linked β-N-acetylglucosamine (O-GlcNAc) transferase (OGT). Although this phosphorylation does not regulate the enzymatic activity of OGT, it inhibits OGT-chromatin association, histone O-GlcNAcylation and gene transcription. Conversely, OGT also O-GlcNAcylates AMPK and positively regulates AMPK activity, creating a feedback loop. Taken together, these results reveal a crosstalk between the LKB1-AMPK and the hexosamine biosynthesis (HBP)-OGT pathways, which coordinate together for the sensing of nutrient state and regulation of gene transcription.

Indexed as

Protein Processing, Post-TranslationalAcetylglucosamineAMP-Activated Protein KinasesChromatinEnergy MetabolismEpigenesis, GeneticGlycosylationHep G2 CellsHistonesHomeostasisHumansN-AcetylglucosaminyltransferasesPhosphorylationTranscription, GeneticAcetylglucosamineAMP-Activated Protein KinasesChromatinHistonesN-AcetylglucosaminyltransferasesPRKAA1 protein, human

Identifiers

PMID24692660
PMCPMC4027166
OpenAlexW2057513702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.